Corrigendum to "Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056]
Author(s):
Özkan, A.; Kapiteijn, E.; Bos, F. van den (0000-0003-1426-3509); Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Blank, C.U.; Bloem, M.; Blokx, W.A.M.; Boers-Sonderen, M.J.; Bonenkamp, J.J.; Eertwegh, A.J.M. van den; Groot, J.W.B. de; Haanen, J.B.; Holtslag, C.E.; Hospers, G.A.P.; Piersma, D.; Rijn, R.S. van; Boer, A.M.S.D.; Suijkerbuijk, K.P.M.; Veldt, A.A.M. van der; Vreugdenhil, G.; Wouters, M.W.J.M. (0000-0001-6173-0662); Portielje, J.E.A.; Glas, N.A. de (0000-0001-8350-4252)
